Identification of factor XIII-A as a marker of alternative macrophage activation

Cellular and Molecular Life Sciences

Volumn 62, Issue 18, 2005, Pages 2132-2139

  Torocsik D ^a   Bardos H ^a   Nagy, L ^a   Adany R ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Alternative activation; Classical activation; Factor XIII A; Gene expression; Macrophage

Indexed keywords

BCG VACCINE; BLOOD CLOTTING FACTOR 13A; GAMMA INTERFERON; INTERLEUKIN 4; MARKER;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MONOCYTE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DENDRITIC CELLS; FACTOR XIIIA; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; MYCOBACTERIUM BOVIS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

MYCOBACTERIUM BOVIS BCG;

EID: 24744469246     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5242-9     Document Type: Article

References (57)

1. Muszbek L., Ádány R. and Mikkola H. (1996) Novel aspects of blood coagulation factor XIII I. Structure, distribution, activation, function. Crit. Rev. Clin. Lab. Sci. 33: 357-421
2. Kisselbach T. H and Wagner R. H. (1972) Demonstration of factor XIII subunit a in the human liver. Thromb. Haemost. 76: 74-79
3. Ádány R., Kiss A. and Muszbek L. (1987) Factor XIII: a marker of mono- and megakariocytopoesis. Br. J. Haematol. 67: 167-172
4. Ádány R. (1996) Intracellular factor XIII: cellular distribution of factor XIII subunit a in humans. Semin. Thromb. Haemost. 22: 399-408
5. Inbal A., Muszbek L., Lubetsky A., Katona E., Levi I., Karpati L. et al. (2004) Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation. Blood Coagul. Fibrinolysis. 15: 249-253
6. Muszbek L., Ádány R., Szegedi G., Polgár J. and Kávai M. (1985) Factor XIII of blood coagulation in human monocytes. Thromb. Res. 37: 401-410
7. Henriksson P., Becker S., Lynch G. and McDonagh J. (1985) Identification of intracellular factor XIII in human monocytes and macrophages. J. Clin. Invest. 76: 528-534
8. Ádány R., Belkin A., Vasilevskaya T. and Muszbek L. (1985) Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur. J. Cell Biol. 38: 171-173
9. Ádány R. and Antal M. (1966) Three different cell types can synthesize factor XIII subunit a in the human liver. Thromb. Haemost. 76: 74-79
10. Kaetsu H., Hashiguchi T., Foster D. and Ichinose A. (1996) Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. J. Biochem. 119: 961-969
11. Ádány R., Kappelmayer J. and Muszbek L. (1987) Expression of factor XIII subunit a in different types of human macrophages. In: The Biology of Phagocytes in Health and Disease, vol. 66, pp. 323-333, Mauri C., Rizzo S. C. and Ricevuti G. (eds), Oxford University Press, New York
12. Ádány R., Bárdos H., Antal M., Módis L., Sárváry A., Szücs S. et al. (2001) Factor XIII of blood coagulation as a nuclear crosslinking enzyme. Thromb. Haemost. 85: 845-851
13. Polgár J., Hidasi V. and Muszbek L. (1990) Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem. J. 267: 557-560
14. Cohen I., Blankenberg T. A., Border D., Kahn D. R. and Veis A. (1980) Factor XIIIa-catalyzed crosslinking of platelet and muscle actin: regulation by nucleotides. Biochim. Biophys. Acta 628: 365-375
15. Cohen I., Young-Bandala L., Blankenberg T. A., Siefring G. E. and Bruner-Lorand J. (1979) Fibrinoligase-catalyzed crosslinking of myosin from platelet and skeletal muscle. 192: 100-111
16. Asijee G. M., Muszbek L., Kappelmayer J., Polgár J., Horváth A. and Sturk G. (1988) Platelet vinculin: a substrate of activated factor XIII. Biochim. Biophys. Acta 954: 303-308
17. Sárváry A. Szücs S., Balogh I., Becsky Á. Bárdos H., Kávai M. et al. (2004) Possible role of factor XIII subunit A in Fcy and complement receptor-mediated phagocytosis. Cell. Immunol. 228: 81-90
18. Lorand L., Losowsky M. S. and Miloszewski K. J. M. (1980) Human factor XIII: fibrin-stabilizing factor. Progr. Haemost. Thromb. 5: 245-290
19. Miloszewski K. J. A. and Losowsky M. S. (1983) Clinical consequences of inherited and acquired factor XIII deficiency. In: Factor XIII and Fibronectin: New Clinical and Biological Aproaches, pp. 31-39, Egbring R. and Klingemann H. D. (eds), Medizinische Verlagsgesellschaft, Marburg/Lahn
20. Seitz R., Duckert F., Lopaciuk S., Muszbek L., Rodeghiero F. and Seligsohn U. (1996) ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin. Thromb. Hemost. 22: 415-418
21. Mantovani A., Sozzani S., Locati M., Allavena P. and Sica A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555
22. Hamilton T. A. (2002) Molecular basis of macrophage activation: from gene expression to phenotypic diversity. In: The Macrophage, pp. 73-102. Burke B. and Lewis C. E. (eds) Oxford University Press, Oxford
23. Stein M., Keshav S., Harris N. and Gordon S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176: 287-292
24. Goerdt S. and Orfanos C.E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142
25. Sallusto F. and Lanzavecchia A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118
26. Becker S. and Daniel E. G. (1990) Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. Cell Immunol. 129: 351-362
27. Schuller S., Neefjes J., Ottenhoff T., Thole J. and Young D. (2001) Coronin is involved in uptake of Mycobacterium bovis BCG in human macrophages but not in phagosome maintenance. Cell. Microbiol. 3: 785-793
28. Steinman R. M. (2000) DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100: 491-494
29. Balint B. L., Szanto A., Madi A., Bauer U. M., Gabor P., Benko S. et al. (2005) Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells. Mol. Cell Biol. 25: 5648-5663
30. Szucs S., Vamosi G., Poka R., Sarvary A., Bardos H., Balazs M. et al. (1998) Single-cell measurement of superoxide anion and hydrogen peroxide production by human neutrophils with digital imaging fluorescence microscopy. Cytometry 33: 19-31
31. Falini B., Flenghi L., Pileri S., Gambacorta M., Bigerna B., Durkop H. et al. (1993) A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am. J. Pathol. 142: 1359-1372
32. Kradin R. L., Lynch G. W. and Kurnick J. T. (1987) Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages. Blood 69: 778-785
33. Nemes Z., Thomázy V., Ádány R., and Muszbek L. (1986) Identification of histiocytic reticulum cells by the immunohistochemical demonstration of factor XIII (FXIII-A) in human lymph nodes. J. Pathol. 149: 121-132
34. Nemes Z., Ádány R. and Thomázy V. (1987) Selective visualization of human dendritic reticulum cells in reactive lymphoid follicles by the immunohistochemical demonstration of the subunit A of factor XIII (FXIII-A). Virhows Arch. (Cell Pathol.) 52: 453-466
35. Ádány R., Glukhova A. M., Kabakov A. Y. and Muszbek L. (1988) Characterization of human connective tissue cells containing factor XIII subunit a. J. Clin. Pathol. 41: 49-56
36. Ádány R. and Muszbek L. (1987) Cells containing factor XIII subunit a in benign and malignant soft tissue tumours. Histopathology 11: 1341-1343
37. Ádány R and Muszbek L. (1989) Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus. Histochemistry 91: 169-174
38. Ádány R. and Bárdos H. (2003) Factor XIII subunit A as an intracellular transglutaminase. Cell. Mol. Life Sci. 60: 1049-1060
39. Horváth A. R., Asijee G. M. and Muszbek L. (1992) Cytoskeletal assembly and vinculin-cytoskeleton interaction in different phases of the activation of bovine platelets. Cell. Motil. Cytoskel. 21: 123-131
40. Zhu Y., Tass L., Lane W. and Mendelsohn M. E. (1994) Specific binding of the transglutaminase platelet factor XIII, to HSP27. J. Biol. Chem. 269: 22379-22384
41. 4 are both actin monomer sequestering proteins. J. Biol. Chem. 268: 502-509
42. Procyk R. and Blomback B. (1988) Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin. Biochim. Biophys. Acta 967: 304-313
43. Sane D. C., Moser T. L., Pippen A. M., Parker C. J., Achyuthan K. E. and Greenberg C. S. (1988) Vitronectin is a substrate for transglutaminases. Biochem. Biophys. Res. Commun. 157: 115-120
44. Prince C. W., Dickie D. and Krumdieck C. L. (1991) Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem. Biophys. Res. Commun. 177: 1205-1210
45. Lynch G. W., Slayter H. S., Miller B. E. and McDonagh J. (1987) Characterization of thrombospondin as a substrate for factor XIII transglutaminase. J. Biol. Chem. 262: 1772-1778
46. Kávai M., Ádány R., Pásti G., Surányi P., Szücs G., Muszbek L. et al. (1992) Marker profile, enzyme activity and function of a human myelomonocytic leukaemia cell line. Cellular Immunol. 139: 531-540
47. Inbal A., Lubetsky A., Krapp T., Castel D., Shaish A., Dickneitte G. et al. (in press) Impaired wound healing in factor XIII deficient mice. Thromb. Haemost.
48. Wozniak G., Dapper F. and Alemany J. (1996) Factor XIII in ulcerative leg disease: background and preliminary clinical results. Semin. Thromb. Hemost. 22: 445-450
49. Ogawa T., Morioka Y., Inoue T., Takano M. and Tsuda S. (1995) Involvement of blood coagulation factor XIII in burn healing in the carbon tetrachloride-induced hepatic injury model in rats. Inflamm. Res. 44: 264-268
50. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A. and Stewart T. A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742
51. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H. et al. (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742-1745
52. Battistini A., Marsili G., Sgarbanti M., Ensoli B. and Hiscott J. (2002) IRF regulation of HIV-1 long terminal repeat activity. J. Interferon Cytokine Res. 22: 27-37
53. Adany R., Nemes Z. and Muszbek L. (1987) Characterization of factor XIII containing macrophages in lymph nodes with Hodgkin's disease. Br. J. Cancer. 1987 55: 421-426
54. Bardos H., Molnar P., Csecsei G. and Adany R. (1996) Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul. Fibrin. 7: 536-548
55. Bardos H., Juhasz A., Repassy G. and Adany R. (1998) Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx. Thromb. Haemost. 80:767-772
56. Adany R. (1993) Janus-faced tumor-associated macrophages. Immunol Today 14: 142-143
57. Probst-Cousin S., Poremba C., Rickert C. H., Bocker W. and Gullotta F. (1997) Factor XIIIa expression in granulomatous lesions due to sarcoidosis or mycobacterial infection. Pathol. Res. Pract. 193: 741-745